Quantitative Proteomic Analysis of the Secretory Pattern of Senescent Cells
衰老细胞分泌模式的定量蛋白质组学分析
基本信息
- 批准号:7187525
- 负责人:
- 金额:$ 14.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-02-15 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAgeAgingAging-Related ProcessApplications GrantsArchitectureArterial Fatty StreakBiological ModelsCell AgingCellsCharacteristicsCodeCultured CellsDiseaseEndothelial CellsEpithelial CellsFibroblastsFutureGenesHumanIn VitroInvestigationIsotopesIsotopically-Coded Affinity TaggingKnowledgeLesionLongevityMalignant NeoplasmsMediatingMessenger RNAMethodsNIH Program AnnouncementsNeoplastic Epithelial CellNormal CellNumbersOncogenicPathologyPatientsPatternPharmaceutical PreparationsPhenotypePreventionProtein SecretionProteinsProteomicsResearch PersonnelSiteStimulusTechnologyTestingTissuesTumor Cell Lineage relatedbasecell typein vivomRNA Expressionneoplastic cellnoveloutcome forecastprogramsras Oncogeneresponsesenescencetumor
项目摘要
DESCRIPTION (provided by applicant): Proliferative senescence of cultured cells is a useful model system to study aging in vitro. In vivo, senescent cells accumulate in aging tissues and at sites of age-related pathologies such as atherosclerotic lesions and preneoplastic lesions, raising the possibility that senescent cells may promote the aging phenotype or age-related pathologies. Indeed, senescent cells were shown to secrete proteins that can alter the function and architecture of the surrounding tissues. In addition to normal cells, tumor cells also undergo proliferative senescence upon treatment with chemotherapeutic drugs. Importantly, many genes that are induced in senescent tumor cells encode secreted proteins with both tumor-promoting and tumor-suppressing activities, which can affect the prognosis of tumor patients. Therefore, the emerging hypothesis is that protein secretion from senescent cells mediates the in vivo aging process and age-related pathologies, as well as the tumor response to therapy. In this context, it is important to note that only a small number of studies have been carried out on proteins secreted from senescent cells and that we still lack comprehensive knowledge of the secretory patterns of normal as well as tumor cells undergoing senescence. Employing a novel quantitative proteomics technology, ICAT (isotope-coded affinity tag), we have developed a method to systematically identify and quantify proteins secreted in culture supernatant, and using this method, we analyzed the secretory pattern of human fibroblasts undergoing replicative senescence. We propose to extend this analysis by 1) comparing the secretory patterns of senescent fibroblasts induced to senesce by different mechanisms, by 2) comparing the secretory patterns of senescent fibroblasts and senescent endothelial cells, and by 3) analyzing the secretory patterns of tumor cells induced to senesce by chemotherapeutic drug treatment. The secretory patterns of senescent cells identified through this exploratory project will provide a basis for future investigations on the fundamental principles governing aging processes as well as more effective treatment and prevention of age-related diseases and cancer.
描述(由申请人提供):培养细胞的增殖衰老是体外研究衰老的有用模型系统。在体内,衰老细胞在衰老组织和与年龄相关的病理部位(例如动脉粥样硬化病变和肿瘤前病变)积聚,增加了衰老细胞可能促进衰老表型或与年龄相关的病理的可能性。事实上,衰老细胞分泌的蛋白质可以改变周围组织的功能和结构。除了正常细胞外,肿瘤细胞在化疗药物治疗后也会经历增殖性衰老。重要的是,衰老肿瘤细胞中诱导的许多基因编码具有促肿瘤和抑肿瘤活性的分泌蛋白,这可以影响肿瘤患者的预后。因此,新出现的假设是,衰老细胞的蛋白质分泌介导体内衰老过程和与年龄相关的病理学,以及肿瘤对治疗的反应。在这种情况下,值得注意的是,仅对衰老细胞分泌的蛋白质进行了少量研究,并且我们仍然缺乏对正常细胞和正在衰老的肿瘤细胞的分泌模式的全面了解。采用新型定量蛋白质组学技术 ICAT(同位素编码亲和标签),我们开发了一种系统鉴定和定量培养上清液中分泌蛋白质的方法,并使用该方法分析了经历复制衰老的人成纤维细胞的分泌模式。我们建议通过以下方式扩展此分析:1)比较通过不同机制诱导衰老的衰老成纤维细胞的分泌模式,2)比较衰老成纤维细胞和衰老内皮细胞的分泌模式,以及3)分析诱导衰老的肿瘤细胞的分泌模式通过化疗药物治疗达到衰老。通过这个探索性项目确定的衰老细胞的分泌模式将为未来研究衰老过程的基本原理以及更有效地治疗和预防与年龄相关的疾病和癌症奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YUZURU SHIIO其他文献
YUZURU SHIIO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YUZURU SHIIO', 18)}}的其他基金
The role of the receptor complex and the cofactors in IGSF10 signaling
受体复合物和辅助因子在 IGSF10 信号传导中的作用
- 批准号:
10728450 - 财政年份:2023
- 资助金额:
$ 14.97万 - 项目类别:
Secretome Proteomics for VHL Tumor Biomarker Discovery
用于 VHL 肿瘤生物标志物发现的分泌蛋白组学
- 批准号:
7740299 - 财政年份:2009
- 资助金额:
$ 14.97万 - 项目类别:
Quantitative Proteomic Analysis of the Secretory Pattern of Senescent Cells
衰老细胞分泌模式的定量蛋白质组学分析
- 批准号:
7348336 - 财政年份:2007
- 资助金额:
$ 14.97万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
The role of extracellular vesicles in keratoconus pathogenesis
细胞外囊泡在圆锥角膜发病机制中的作用
- 批准号:
10595121 - 财政年份:2023
- 资助金额:
$ 14.97万 - 项目类别:
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:
10717825 - 财政年份:2023
- 资助金额:
$ 14.97万 - 项目类别:
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
量化血浆中的蛋白质确实使 1 型糖尿病患者的个性化医疗民主化
- 批准号:
10730284 - 财政年份:2023
- 资助金额:
$ 14.97万 - 项目类别:
Characterizing molecular phenotypes of pancreatic islet reactive B cells in T1D through single cell sequencing
通过单细胞测序表征 T1D 中胰岛反应性 B 细胞的分子表型
- 批准号:
10600510 - 财政年份:2023
- 资助金额:
$ 14.97万 - 项目类别:
Protease-activated-receptor-2 antagonists for treatment of migraine pain
蛋白酶激活受体 2 拮抗剂治疗偏头痛
- 批准号:
10602826 - 财政年份:2023
- 资助金额:
$ 14.97万 - 项目类别: